Low Back Pain
Conditions
Keywords
Persistent Non-specific Low Back Pain, wet cupping, cupping, Numerical Rating Scale
Brief summary
The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Waiting Control group.
Interventions
DEVICEWet Cupping
Wet cupping (Seongho trade & company, Korea) will be practiced at two selected points (among the 6 acupoints, left or right BL23, BL24, BL25)
DRUGAcetaminophen
Acetaminophen 500 mg tablets will be offered to both of the wet cupping group and waiting group for relieving severe pain.
Sponsors
Korea Institute of Oriental Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Patients who have had non-specific low back pains at least 12 weeks now.
Exclusion criteria
* Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome). * Patients who are inappropriate to the wet cupping treatment. * AIDS, Active Hepatitis, Tuberculosis, Syphilis * Patients who regularly take anticoagulants, antiplatelet drugs * Anemia, thrombocytopenia * Hemorrhagic disease like hemophilia * Diabetes * Severe cardiovascular disease * Kidney diseases (renal failure, chronic renal disease) * Patients who have experiences of wet cupping treatment during last 3 months. * Patients who have had treatment for low back pain during last 2 weeks. * Patients who are in pregnancy or have plan to conception. * Patients who have vertebra surgery or have plan of surgery. * Patients who are inappropriate to join this trial judged by the radiologists or specialists.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric Rating Scale (NRS) for pain | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
Secondary
| Measure | Time frame |
|---|---|
| Present Pain Intensity Scale of the McGill Pain Questionaire (PPI) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| Oswestry Disability Questionnaire (ODQ) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| Medication Quantification Scale (MQS) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| General Assessment of Doctors and Subjects | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| Safety measurement | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
Countries
South Korea
Outcome results
None listed